 |
|
Leukemia Trial Results
1. Nilotinib Effective and Safe in Initial Treatment of Chronic Leukemia 3
(Posted: 12/28/2009) - Preliminary results from a phase III trial testing nilotinib (Tasigna) against imatinib mesylate (Gleevec) as first-line treatment for chronic-phase chronic myelogenous leukemia (CML) indicate that nilotinib is effective and safe as initial treatment for this disease.
2. Young Adults with Acute Lymphoblastic Leukemia Do Well on Intensified Pediatric Chemotherapy Regimen 4
(Posted: 11/30/2009) - Adolescents and young adults with acute lymphoblastic leukemia lived longer when treated with an intensified multi-drug chemotherapy regimen that is used to treat younger children, according to the November 1, 2009, Journal of Clinical Oncology.
3. Imatinib Added to Chemotherapy Keeps Disease in Check for Longer in Children with Rare Form of Acute Lymphoblastic Leukemia 5
(Posted: 11/30/2009) - The addition of the targeted drug imatinib to chemotherapy for children with an uncommon form of acute lymphoblastic leukemia (ALL) dramatically improved the length of time the disease remained in remission, according to the November 1, 2009, Journal of Clinical Oncology.
4. Donated Stem Cell Transplants Better than Self-transplants for Most Patients with AML 6
(Posted: 07/23/2009) - Evidence from a meta-analysis of prospective clinical trials supports the use of donated (or allograft) stem cell transplants to treat most individuals with acute myeloid leukemia, according to the June 10, 2009, Journal of the American Medical Association.
5. For Children with Leukemia, Radiation May Be Unnecessary 7
(Posted: 07/23/2009) - Children with the most common form of leukemia can safely forego radiation therapy to prevent relapse if they are treated with chemotherapy regimens tailored to their individual needs, according to the June 25, 2009, New England Journal of Medicine.
1 2 8 3 9 4 10 Next > 8
|
Table of Links
| 1 | http://www.cancer.gov/cancertopics/types/leukemia |
| 2 | http://www.cancer.gov/clinicaltrials/search |
| 3 | http://www.cancer.gov/clinicaltrials/results/nilotinib-cml1209 |
| 4 | http://www.cancer.gov/clinicaltrials/results/ALLpediatric1109 |
| 5 | http://www.cancer.gov/clinicaltrials/results/ALLimatinib1109 |
| 6 | http://www.cancer.gov/clinicaltrials/results/AMLtransplants0709 |
| 7 | http://www.cancer.gov/clinicaltrials/results/leukemia-radiation0709 |
| 8 | http://www.cancer.gov/clinicaltrials/results/leukemia?keyword=any+leukemia&page
=2 |
| 9 | http://www.cancer.gov/clinicaltrials/results/leukemia?keyword=any+leukemia&page
=3 |
| 10 | http://www.cancer.gov/clinicaltrials/results/leukemia?keyword=any+leukemia&page
=4 |
|
|
